If you have been diagnosed with iron deficiency with or without anemia, it may seem like an easy fix. "I'll just take some iron tabs, and everything will be fine." Although this is true for many ...

Efgartigimod alfa-fcab (Vyvgart) is a human IgG1 antibody fragment. It is formulated as concentrated solution for infusion for intravenous and solution for subcutaneous route of administration.

The company's lead product, VYVGART (efgartigimod), has shown impressive performance in treating myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP), positioning argenx ...

The company’s lead product, VYVGART (efgartigimod), has shown impressive performance in treating myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP), positioning argenx ...

The company significantly exceeded market expectations with its Vyvgart product, reporting $737 million in worldwide net revenue for the fourth quarter of 2024, which is a 15% increase over the ...

The company's lead product, VYVGART (efgartigimod), has shown impressive performance in treating myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP), positioning ...

“2024 was a transformative year as we significantly expanded our global patient reach with VYVGART and advanced a world-class pipeline of precision therapies,” said Tim Van ...

“2024 was a transformative year as we significantly expanded our global patient reach with VYVGART and advanced a world-class pipeline of precision therapies,” said Tim Van Hauwermeiren, Chief ...